Direct-acting antivirals
61 articles
Adoption of New Therapies in the Treatment of Hepatitis: A Verification of the Accuracy of Budget Impact Analysis to Guide Investment Decisions
A study compared the results between theoretical and real-world evidence expenditures for medicines for hepatitis C: boceprevir and telaprevir. More
DAA Treatment Failures in a Low-Resource Setting with a High Burden of Hepatitis C: a Case Series
A case report discussed a series of 18 HCV patients within a resource-limited setting, who after failing standard regimen also failed to respond to advanced pan-genotypic treatment regimens. More
Fibrosis Stage-Specific Incidence of Hepatocellular Cancer After Hepatitis C Cure With Direct-Acting Antivirals
A systematic review and meta-analysis assessed HCC incidence or outcomes by cirrhosis status and fibrosis stage, in adults with HCV who achieved sustained virologic response after DAAs. More
Efficacy and Safety of Direct-Acting Antiviral Therapies and Baseline Predictors for Treatment Outcomes in Hepatitis C Patients in China
A multicenter, real-world study evaluated the efficacy and safety of direct-acting antiviral regimens among chronic hepatitis C patients in Guangdong, China. More
Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis
Safety and effectiveness using 8 weeks of glecaprevir/pibrentasvir in HCV-infected treatment-naïve patients with compensated cirrhosis: The CREST study More
